Clicky

uniQure N.V.(QURE) News

Date Title
Sep 23 uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease
Aug 3 uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 1 UniQure restructuring to claim 300 jobs
Aug 1 UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates
Aug 1 UniQure: Q2 Earnings Snapshot
Aug 1 uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
Jul 26 Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High?
Jul 23 uniQure Announces Closing of Sale of Manufacturing Facility to Genezen
May 9 uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 7 uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Mar 13 13 Best Biotech Stocks To Buy Under $20
Dec 19 Investors still aren’t sold on UniQure’s gene therapy for Huntington’s
Dec 19 uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
Dec 12 CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B
Dec 10 12 Best Genomics Stocks To Buy Now
Dec 2 Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago
Nov 29 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
Aug 6 Analysts Are More Bearish On uniQure N.V. (NASDAQ:QURE) Than They Used To Be
Jun 22 Why uniQure Stock Cratered This Week
Jun 22 uniQure (QURE) Falls on Mixed Huntington's Disease Study Results